trial

Effectiveness and Mechanisms of Recovery Oriented Cognitive Therapy

NCTId NCT05140135
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Withdrawn
Enrollment 0 (actual)
Sponsored by University of Pennsylvania
Primary completion 2024-12-31
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Withdrawn
Enrollment
0 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
None
Start
2021-01-11
Primary completion
2024-12-31
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Recovery Oriented Cognitive Therapy (CT-R)

Sponsors

University of PennsylvaniaLead Sponsor

Sites

1 total
Philadelphia, United States

Facts & assertions

4 sourced
Enrollment
0
Phase
NA
Primary Completion Date
2024-12-31
Status
WITHDRAWN
relationships
The graph out of here
drug
Recovery Oriented Cognitive Therapy (CT-R)
drug
lead_sponsor
University of Pennsylvania
company
indication
Schizophrenia
indication
Schizoaffective Disorder
indication
Schizophrenia
indication